The most honest measure of a climate tech company is not its pitch deck, but the size of its pipes. In a converted sugar refinery in Sas van Gent, Netherlands, ENOUGH has built a pipe that can produce 10,000 tonnes of protein a year. It is a quiet, industrial-scale bet that the future of food will be won by ingredient suppliers, not by brands fighting for shelf space.
ENOUGH makes ABUNDA, a mycoprotein derived from fermenting fungi with sugars from grains. It is a complete protein, high in fiber, and neutral in taste, designed to be a plug-and-play ingredient for food manufacturers. The company sells it to the companies that make the vegan burgers, chicken nuggets, and dairy alternatives that end up in supermarkets and fast-food chains. This B2B model, led by former Quorn executive Jim Laird, is a deliberate choice to avoid the marketing wars and focus on scaling production at a cost that can compete with animal protein on economics alone.
The industrial logic of white-label protein
Mycoprotein is not new. Quorn, the dominant consumer brand, has been selling it for decades. ENOUGH's wedge is not the organism, but the business model. By operating solely as an ingredient supplier, it aims to become the invisible engine for a wide array of food companies. Its announced partners read like a who's who of the food industry: Unilever is testing ABUNDA in its The Vegetarian Butcher line, Cargill is co-creating products with it, European poultry processor Plukon Food Group uses it for meat analogues, and manufacturers supplying UK supermarket M&S are on board [greenqueen.com.hk].
This strategy turns every major food company into a potential customer, not a competitor. It also aligns with the brutal unit economics of climate impact. The sustainability claims are significant,ABUNDA uses 97% less feed and 99% less water than red meat, with 95% lower CO2 emissions [enough-food.com]. But for a food manufacturer under margin pressure, those stats are a bonus. The primary question is whether ABUNDA can be produced cheaply and reliably enough at scale to be a viable swap for soy, pea, or animal protein. The $110 million in funding, and the construction of a dedicated 10,000-tonne-per-year facility, is ENOUGH's answer.
Scaling the Sas van Gent pipeline
The company's trajectory is now tied to the output of its Dutch plant, which came online in late 2022 [foodmanufacture.co.uk]. The plan is to double that initial capacity to 20,000 tonnes by early 2025, with the site having an ultimate potential of 60,000 tonnes [foodnavigator.com, agfundernews.com]. These are the numbers that matter. ENOUGH's stated vision is to produce one million tonnes of mycoprotein by 2032 [enough-food.com]. Hitting that target would require building the equivalent of about sixteen more facilities at the expanded scale of the Dutch site.
The funding rounds, led by strategic players like Nutreco and World Fund, suggest investors believe the capital expenditure is justified. The table below outlines the disclosed capital raised to build this capacity.
2021 Series B | 51 | M USD
2023 Growth Round | 43.5 | M USD
Total Disclosed | 110.82 | M USD
Where the fermentation could falter
For all its industrial logic, ENOUGH's path is not without fermentation risks. The market for alternative proteins is volatile, with consumer brands rising and falling. As a B2B supplier, ENOUGH is insulated from fickle retail trends, but it is exposed to the success of its customers. If a major partner's product line fails, that demand for ABUNDA evaporates.
The competitive field is also getting crowded. While Quorn remains the consumer giant, a host of new companies are targeting the same B2B and B2C spaces with different technologies.
| Company | Primary Product | Model | Notable Backers/Traits |
|---|---|---|---|
| ENOUGH | Mycoprotein (ABUNDA) | B2B Ingredient | Former Quorn exec leadership; Cargill, Unilever partners |
| Nature's Fynd | Fungal protein (Fy) | B2B & B2C | Breakthrough Energy Ventures |
| Meati | Mycelium steaks & cuts | B2C | |
| The Protein Brewery | Fungal fermented protein | B2B Ingredient | |
| Quorn | Mycoprotein foods | B2C Brand | Market incumbent; owned by Monde Nissin |
Finally, there is the sheer execution risk of scaling biology. Fermentation at this volume is a feat of process engineering. Hiccups in yield, contamination, or energy use can erase margin advantages. ENOUGH's team, a spin-out from the University of Strathclyde with deep industry experience, is built for this challenge [Sifted]. But the proof will be in the consistent, cost-effective tonne.
The next twelve months and the final calculation
The immediate milestone is clear: successfully doubling output at the Sas van Gent facility to 20,000 tonnes per year by early 2025. Hitting that target on schedule and budget would be the strongest signal yet that the model works. It would also likely trigger the next major funding round, needed to finance the replication of this plant elsewhere.
Success for ENOUGH is not measured in brand awareness, but in displacement. A back-of-the-envelope calculation shows the stakes: producing 20,000 tonnes of ABUNDA instead of an equivalent amount of beef would, by the company's figures, save roughly 1.9 billion kilograms of CO2, 19.8 billion liters of water, and enough animal feed to fill about 380 Olympic swimming pools [enough-food.com].
The company it must beat is not a flashy startup, but the entrenched supply chain of industrial animal agriculture. ENOUGH is betting that food manufacturers, when given a cheaper, greener, and functionally identical ingredient, will quietly rewrite their recipes. It is a bet on the power of the pipe.
Sources
- [Business Insider, August 2023] Fungi-based meat alternative startup Enough, founded by a former Quorn boss, just raised $43.5 million | https://www.businessinsider.com/enough-fungi-based-meat-alternative-startup-raises-435-million-2023-8
- [enough-food.com] ENOUGH - delicious, nutritious, sustainable | https://www.enough-food.com/
- [foodmanufacture.co.uk, September 2022] ENOUGH opens first commercial-scale plant | https://www.foodmanufacture.co.uk/Article/2022/09/20/enough-opens-first-commercial-scale-plant
- [foodnavigator.com, August 2023] ENOUGH to double mycoprotein production capacity | https://www.foodnavigator.com/Article/2023/08/21/enough-to-double-mycoprotein-production-capacity
- [greenqueen.com.hk] ENOUGH partners with Unilever, M&S, Plukon, and Cargill | https://www.greenqueen.com.hk
- [Sifted] ENOUGH: The Scottish startup that raised €40M for alternative meat | https://sifted.eu/articles/scottish-startup-enough-40m-for-alternative-meat-news
- [TheCompanyCheck] ENOUGH company financials | https://www.thecompanycheck.com/company/b/enough/k81g02j1vgi664l1v